Mental Health Problems
in Autism
Travis Thompson, PhD, LP
Most people with autism encounter difficulties with anxiety, especially social anxiety. This fearfulness can lead to a mental health diagnosis of Agoraphobia (intense fear of being away from a safe setting, usually home) of Generalized Anxiety Disorder. In addition, most people with ASDs experience the feeling that activities must be done in a very particular way or that physical objects in their environment must be arranged in a uniquely idiosyncratic way. Many children and youth with autism have attention problems, i.e. focusing on instructional or work materials specified by a parent, teacher or supervisor. Social anxiety, ritual behaviour and attention difficulties are inherent parts of autism, though in extreme cases psychologists or psychiatrists may assign a separate secondary diagnostic label to the additional condition, e.g. Obsessive Compulsive Disorder, ADHD, Social Phobia, which can lead to a more specific treatment for that condition, much as others without autism might receive.
It is very difficult to differentially diagnose these conditions, because at times many people with ASDs may display symptoms of other conditions without actually having that condition, but may do so only infrequently and sporadically. Since most mental health diagnoses depend on the person’s emotional expressions (sadness), comments about their own mental state (confused, forgetful), both of which are impaired in autism, the clinician is left to infer from indirect information and interviews with caregivers.
It is risky for a clinician who has never seen an individual before to arrive at a diagnosis based on the current presentation alone. Without baseline information about that person, for example grandiosity, that may inadvertently lead to a Bipolar Disorder diagnosis, while in fact the person frequently says unrealistic things in their day to day life. Symptoms of depression are especially difficult to differentiate from those of autism, and unless one has an idea of the person’s behavior and appearance six months or a year earlier, there is no way to know whether his/her current status is different from baseline (e.g. lack of talkativeness, withdrawn, lack of positive emotion, loss of interest in favorite activities). Clinicians experienced with other disability populations, such as intellectual disabilities, are often more aware of these problems.
Intervention protocols for individuals with combined conditions must take each diagnosis into consideration. Parents are understandably wary of over prescribing psychotropic medications. While this is understandable, it is important that they are made aware that some medications used judiciously can be very beneficial to their adolescent child, such as Selective Serotonin Reuptake Inhibitors (Proazac) for phobias and severe OCD rituals. Few experienced professionals would contend medication alone will solve the person’s problems, but in some cases, e.g. Bipolar Disorder, or Atypical Antipsychotic for a person with schizophrenia and autism, it can be critical. Treatment teams need to carefully think through each of the person’s diagnoses, e.g. Panic Attack Disorder and Autism (High Functioning), and tailor make a treatment plan for each that is integrated across the two diagnoses. This is a realm in which well trained behavior analysts working closely with prescribing physicians and their nursing staff can play an important role in monitoring medication effects and reporting back on results (both favorable and side effects).
Bibliography
Guttman-Steinmetz, S. et.al J Autism Dev Disord. 2009 Jul;39(7):976-85.
Raja, M. et.al. Clin Pract Epidemiol Ment Health. 2011; 7: 97–105.
Published online 2011 March 30.
Tsai, L and Mesibov, GB (2001) Taking the mystery out of medications in Autism/Asperger syndromes. Future Horizons, Inc.
Volkmar, FR and Cohen, DJ, (1991) The American Journal of Psychiatry 148(12):1705-1707
Bibliography
Guttman-Steinmetz, S. et.al J Autism Dev Disord. 2009 Jul;39(7):976-85.
Raja, M. et.al. Clin Pract Epidemiol Ment Health. 2011; 7: 97–105.
Published online 2011 March 30.
Tsai, L and Mesibov, GB (2001) Taking the mystery out of medications in Autism/Asperger syndromes. Future Horizons, Inc.
Volkmar, FR and Cohen, DJ, (1991) The American Journal of Psychiatry 148(12):1705-1707